Press - News - 504 - Research Study Announcement: Certolizumab Pegol in Subjects With Active Axial Spondyloarthritis
Links shared publicly online about this topic.
- 216total visits
Press - News - 504 - Research Study Announcement: Certolizumab Pegol in Subjects With Active Axial Spondyloarthritis
Ankylosing spondylitis and related disease information. Ankylosing spondylitis symptoms, diagnosis, treatment, medication, educational materials, brochures. Spondylitis patient support, message boards, physician resources and more. SAA is a non-profit organization and we were the first and remain the largest resource for people affected by spondylitis in the United States.
View full resource at spondylitis.org
Tags: Crohn's Disease Medication, Ankylosing Spondylitis, Drug, Phase 3 Clinical Trial, Clinical Trial, Cimzia, News
Most Recently Shared on June 15, 2011 at 9:01 pm By:
Phase 3 Clinical Trial with biologic drug, certolizumab pegol (Cimzia) for #Spondylitis patients http://t.co/Fyr47rS Now recruiting. #rheum
Advertisement
